ACTRN12622000267752已完成2 期
The effect of treatment with intra-vitreal bevacizumab 0.05ml combined with supra-choroidal triamcinolone 0.05ml on macular thickness and visual acuity in central retinal vein occlusion patients.
Salahuddin0 个研究点目标入组 34 人开始时间: 2022年2月14日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 20 Years 至 o limit（—）
- 性别
- All
入选标准
- •1, All those patients diagnosed with central retinal vein occlusion
- •2, Either gender (male/female)
排除标准
- •1,All those patients having poor compliance and follow up
- •2,All Known glaucomatous or glaucoma suspected patients
- •3,Eyes with opaque media in which fundus assessment was not possible like, dense cataracts, corneal opacity, vitreous bleed etc.
- •4,Eyes with prior lasers or injections done.
- •5,Eyes with complications like neo-vessels on disc and else-where in fundus and anterior segment neo-vessels.
- •6,Eyes with active inflammation or infection like conjunctivitis etc.
研究者
相似试验
已完成
不适用
The effect of intra-vitreal injection of bevacizumab for vascular endothelial factor-related intraocular diseases.choroidal neovascularization, retinal vein occlusion, diabetic retinopathy, diabetic maculopathy, neovascular glaucomaJPRN-UMIN000013974Department of Ophthalmology, Matsumoto Dental University3
已完成
不适用
Safety and effectiveness of intravitreal bevacizumab and ranibizumab injections for treatment of retinal disease patients: an observational studyretinal diseases or conditions that can be treated with bevacizumab or ranibizumab such as neovascular age-related macular degeneration (neovascular AMD),diabetic macular edema (DME),and macular edeneovascular age-related macular degeneration (neovascular AMD)diabetic macular edema (DME)retinal vein occlusion(RVO)TCTR20141002001Health Intervention and Technology Assessment Program (HITAP)6,399
已完成
3 期
Comparison of intravitreal Bevacizumab (Avastin) injection alone or in combination with Diclofenac in the treatment of diabetic macular edemaDiabetic retinopathy.Diabetic retinopathyIRCT201512144786N3Isfahan University of Medical Sciences68
已完成
不适用
The effect of intravitreal injection of bevacizumab after vitrectomy for proliferative diabetic retinopathyproliferative diabetic retinopathyJPRN-UMIN000009801Tokyo medical university20
已完成
不适用
Evaluation of Intravitreal injection of Bevacizumab for treatment of Chronic Central Serous Chorioretinopathychronic central serous chorioretinopathy.Disease of the eye and adnexaIRCT201202198983N1Guilan Universoty of Medical Sciences, Pro-vice-chancellor for resea15